FDA Device recall Z-2149-2014
SIEMENS ADVIA Centaur CP Immunoassay System BNP kit
- FDA Device
- Class II
- terminated
- Published 2014-08-13
On 2014-08-13 the FDA classified a Class II recall of SIEMENS ADVIA Centaur CP Immunoassay System BNP kit by Siemens Healthcare Diagnostics, citing complaints of failed calibration.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-2149-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-06-23 |
| Published | 2014-08-13 |
| Last updated | 2026-09-13 11:53 UTC |
| Company | Siemens Healthcare Diagnostics |
| Distribution | US |
Product
SIEMENS ADVIA Centaur CP Immunoassay System BNP kit; SMN 10309044 - 100 test For in vitro diagnostic use in the quantitative determination of B-type Natriuretic Peptide (BNP) in human plasma using the ADVIA Centaur CP System.
Reason
Complaints of failed calibration.
Identifiers
| code_info | Lot# 38479172 and 39181172 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2149-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.